BRN (ASX) 2021 BRN Discussion

Originally posted by Pharvest: ↑

OK I'm going to weigh in on this Nanose device. Please don't read this as a BRN down ramp as I have put a considerable amount on BRN after learning of the Renesas deal and NASA, Ford etc trialling the technology and I hope it goes to the moon someday soon as much as anyone who is invested.

Having had a quick poke around looking into the literature available on the Nanose, I cannot find anything that gives guidance on at what stage of infection this device is able to detect Covid19? This is incredibly important if this device is to be considered useful as a screening device.

Don't get me wrong I think the fact that Akida can be used in this device to pick up covid, cancers and any other deadly condition is incredible I just think from reading the threads there appears to be a few who can't understand why the Nanose announcement hasn't put a rocket under the share price. I'm just here to point out that when it comes to Covid 19 testing there are a lot of things to consider. For instance, is this device detecting the antibodies an infected person's body produces to fight the infection or the antigen ( virus ) itself? This makes a huge difference if a device is to be used to stop the spread. A person may be asymptomatic ( and infectious ) for up to three weeks before developing antibodies to the disease, if it is covid antibodies the device is detecting I wouldn't be holding out a great amount of hope for Nanose becoming a global sensation in Covid screening. Does anyone have more information on the sensitivity and specificity of the test? It's easy to say we can detect Covid but there are a plethora of rapid antigen and antibody tests on the market that can do that in 15 mins already, for me this device is going to have to be extremely accurate to warrant too much excitement about it, and I can't find any info available as yet that leads me to believe this will be the case. The data may come back soon that it is the most accurate test available but until we have said data available the jury is most definitely out.

I have developed a pretty good knowledge base on Covid19 Tests and testing through being invested in Brisbane based Anteotech ( ADO ). Their anteobind technology underpins the Ellume home tests that have made headlines recently with the US department of defence throwing nearly 300 million behind them including building a new factory in Maryland to manufacture their test. Anteotech are about to launch their own antigen rapid test at the end of this quarter once they have the results of the clinical trial that is being conducted by the Victorian infectious diseases reference laboratory a department of the world renowned Dougherty Institute. Anteotech are already very confident our results will mirror our own findings in that our lower limit of detection ( LLOD ) is very very low, in fact this is somewhat already validated in that it is the Anteobind in the Ellume tests that makes them so accurate. It is said to be almost on par with the polyrase chain reaction ( PCR ) tests that are performed in the labs- and are the only test allowed by the Australian government at this stage. So again this test detects the infinitesimally small virus itself within days of infection and can actually detect it before a carrier has themselves become infectious.. this is a huge point. The company has also engaged Novotech to conduct a further trial in India on live patients using both the nasal swab sample and a saliva sample. They believe their tech is that accurate that they will be able to offer a highly accurate test utilising saliva samples alone which will be a big game changer... anyone who has had a Covid test in the last year I'm sure will understand why I say this.. My eyes are still watering from the last 'brain probe' I experienced at Christmas time. The company have manufacturing in Europe ready to begin by Operon of Spain and will also be manufacturing and exporting from Australia they have also stated stating they are seeking manufacturing partners in Asia and the US.

I still believe that a device such as Nanose is an incredible leap forward and bloody amazing quite frankly. To think that you may be able to just one day give a quick blow into it at your GP's office while having a check up and be instantly screened for several different types of deadly cancers etc, that is an amazing thing to be a small part of by way of your investment in BRN. I just think that some may need to temper their expectations on an exploding SP brought on by massive uptake of this device in the fight against Covid, there is still a lot more hard data that needs to come out on how effective it will be.

Regardless of Nanose the shares of BRN are extremely undervalued at the moment just based on everything else they've got going on in my opinion.

GLTA, Pharvest

Expand

it didn't put a rocket under the share price because
A) all of us already knew about it
B) nanose had already done a huge round of press in August last year, eg .

https://www.israel21c.org/breathalyzer-from-israel-a-gamechanger-for-covid-testing/

New breath test sniffs out Covid-19 in 30 seconds

the next set of clinical studies should provide more answers

No.	Vol.	Price($)
6	110458	22.0¢

No.

Vol.

Price($)

110458

22.0¢

Price($)	Vol.	No.
22.5¢	355185	24

Price($)

Vol.

No.

22.5¢

355185

No.	Vol.	Price($)
6	110458	0.220
16	465666	0.215
23	548788	0.210
22	841623	0.205
60	1870008	0.200

No.

Vol.

Price($)

110458

0.220

465666

0.215

548788

0.210

841623

0.205

1870008

0.200

Price($)	Vol.	No.
0.225	355185	24
0.230	563156	16
0.235	582441	18
0.240	398618	13
0.245	587269	12

Price($)

Vol.

No.

0.225

355185

0.230

563156

0.235

582441

0.240

398618

0.245

587269

(20min delay)
Last 22.0¢		Change -0.005(2.22%)		Mkt cap ! $408.3M

Open	High	Low	Value	Volume
22.5¢	22.5¢	21.8¢	$1.107M	5.019M

it didn't put a rocket under the share price becauseA) all of us...

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Recce's R327 found effective against E.coli during clinical trial

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

it didn't put a rocket under the share price becauseA) all of us...

Top Stories

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Recce's R327 found effective against E.coli during clinical trial

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News